Jing Huang – InmunoES

Anlotinib combined with chemoradiotherapy for postoperative isolated lymph node recurrence of ESCC: a phase II study

24 de July de 2026 by Jing Huang

BackgroundPostoperative lymph node recurrence in esophageal squamous cell carcinoma (ESCC) is associated with poor prognosis and lacks standardized treatment. Radioresistance and aberrant immune/inflammatory tumor microenvironment (TME) are major barri…

Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study

11 de November de 2025 by Jing Huang

BackgroundThe 2021 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend immunotherapeutic regimens for idiopathic membranous nephropathy (IMN), including glucocorticoids (GC) with cyclophosphamide (CYC) or calcineurin inhibitors (CNIs…